Certified by Founder Lodge
Angitia Biopharmaceuticals
United States - Woodland Hills, CA
START UP
1 Disclosed Funding Rounds $120,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 12 ,2024 | Series C | $120,000,000 |
Bain Capital
Janus Henderson Investors
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Onsetto | $2,200,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
